Skip to main content
. 2018 Sep 3;18:865. doi: 10.1186/s12885-018-4780-0

Table 1.

Clinicopathological characteristics of gastric cancer patients

Characteristics Well, n (%) Moderately, n (%) Poorly, n (%) P value
Age < 0.001
  ≤ 60 197(10.8) 406(22.2) 1226(67.0)
 >60 173(13.7) 430(34.1) 658(52.2)
Gender < 0.001
 Male 308(12.7) 716(29.6) 1398(57.7)
 Female 62(9.3) 120(18.0) 486(72.7)
Tumor location < 0.001
 Upper third 146(14.9) 351(35.7) 485(49.4)
 Middle third 47(9.3) 108(21.4) 350(69.3)
 Lower third 163(12.0) 329(24.2) 867(63.8)
 Cross or entire 14(5.7) 48(19.7) 182(74.6)
Tumor size < 0.001
  ≤ 5 332(15.3) 613(28.2) 1228(56.5)
 >5 38(4.2) 223(24.3) 656(71.5)
Tumor depth < 0.001
 T1 193(32.9) 165(28.2) 228(38.9)
 T2 49(10.1) 153(31.5) 284(58.4)
 T3 96(8.6) 351(31.4) 670(60.0)
 T4 32(3.6) 167(18.5) 702(77.9)
Lymph node metastasis < 0.001
 N0 274(24.2) 360(31.8) 498(44.0)
 N1 52(8.8) 200(33.8) 340(57.4)
 N2 27(5.1) 142(26.8) 361(68.1)
 N3 17(2.0) 134(16.0) 685(82.0)
Tumor stage < 0.001
 I 225(28.9) 241(31.0) 312(40.1)
 II 93(10.1) 316(34.3) 511(55.6)
 III 52(3.7) 279(20.1) 1061(76.2)